Last reviewed · How we verify

NCT06875830

Comparison of Immediate Implant Placement With Titanium Mesh Versus Collagen Membrane in Type II Socket:

Active, enrolled NA Last updated 13 January 2026
What this trial tests

NA trial testing collagen membrane in Bone Augmentation in 20 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
6 March 2025
Primary endpoint
1 July 2026
1 September 2026

Quick facts

Lead sponsorMisr International University
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment20
Start date6 March 2025
Primary completion1 July 2026
Estimated completion1 September 2026
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Misr International University

Who can join

Adults 21 to 50, any sex, with Bone Augmentation or Badly Broken Maxillary Premolars Indicated for Extraction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Statement of the problem: Immediate implant placement is faced with several problems. One of the most important issues is dealing with defects in the buccal plate of bone in the esthetic zone. Aim: The aim of this study is to assess the buccal bone thickness after augmentation with titanium mesh and xenograft upon flapless immediate implant placement.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of collagen membrane

Trials testing the same drug.

Other recruiting trials for Bone Augmentation

Currently open trials in the same condition.

Other Misr International University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06875830.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing